Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Clin Pract Cases Emerg Med ; 8(3): 211-214, 2024 Aug.
Article in English | MEDLINE | ID: mdl-39158233

ABSTRACT

Introduction: Acute hematogenous osteomyelitis may have significant morbidity and mortality if undiagnosed. Because it is uncommon in developed countries and has variable presentations, the patient may undergo several healthcare visits prior to diagnosis. Case Report: We report the case of a 9-year-old male who presented with hip and knee pain with associated fevers and was found to have osteomyelitis and intraosseous abscess in the diaphysis of the right femur. He had multiple emergency department and outpatient visits before the ultimate diagnosis was made. He was treated with irrigation and debridement in addition to intravenous antibiotics. Conclusion: Pediatric acute hematogenous osteomyelitis can have subtle presentations, and this case illustrates some of the difficulties in making the diagnosis. This condition should be considered in the workup of a child with undifferentiated fever, pain, or decrease in mobility.

2.
Phytother Res ; 26(9): 1371-4, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22294419

ABSTRACT

Biofilm producing bacteria such as Staphylococcus species and Escherichia coli are the most common cause of catheter related urinary tract infections (UTIs). The American cranberry (Vaccinium macrocarpon) is utilized widely as a prophylaxis for UTIs due to its prevention of microbial adhesion. Cranberry contains proanthocyanidins (PACs), which have been implicated as active constituents responsible for its bacterial antiadhesive properties. Despite overwhelming data supporting cranberry's beneficial effects against human pathogenic bacteria, there is limited information regarding its effects on biofilm formation. This study evaluated the effects of three proprietary PAC-standardized cranberry extracts on the inhibition of bacterial growth and biofilm production against a panel of clinically relevant pathogens: Staphylococcus epidermidis, Staphylococcus aureus, clinical methicillin-resistant S. aureus (MRSA), Staphylococcus saprophyticus and Escherichia coli. The extracts inhibited the growth of the Gram-positive bacteria (Staphylococcus spp.) but not the Gram-negative species (E. coli) with minimum inhibitory concentrations in the range 0.02-5 mg/mL. The extracts also inhibited biofilm production by the Gram-positive bacteria but did not eradicate their established biofilm. These results suggest that cranberry may have beneficial effects against the growth and biofilm producing capability of Gram-positive bacteria pathogens.


Subject(s)
Biofilms/drug effects , Escherichia coli/drug effects , Plant Extracts/pharmacology , Staphylococcus/drug effects , Vaccinium macrocarpon/chemistry , Anti-Bacterial Agents/pharmacology , Bacterial Adhesion/drug effects , Fruit/chemistry , Microbial Sensitivity Tests , Plant Extracts/chemistry , Proanthocyanidins/pharmacology
3.
J Spec Oper Med ; 21(2): 80-84, 2021.
Article in English | MEDLINE | ID: mdl-34105127

ABSTRACT

Although skin and soft tissue infections are common in the deployed setting, infectious myositis is relatively uncommon. Bacterial infection of the muscle is the most common infectious etiology and can result in a spectrum of disease, to include abscess formation to necrotizing myositis, toxic shock syndrome, and death. Diagnosis can be elusive, particularly in the early stages. Recognition and proper management are crucial to prevent complications. The authors present a case report of infectious myositis diagnosed and managed in an austere deployed environment, as well as a discussion regarding current recommendations on diagnosis and treatment.


Subject(s)
Fasciitis, Necrotizing , Myositis , Shock, Septic , Soft Tissue Infections , Streptococcal Infections , Humans , Myositis/diagnosis , Myositis/therapy
4.
Med J (Ft Sam Houst Tex) ; (PB 8-21-01/02/03): 28-33, 2021.
Article in English | MEDLINE | ID: mdl-33666909

ABSTRACT

Coronavirus 2019 (COVID-19) has spread across the globe with a concerningly high infectivity resulting in the World Health Organization deeming it a pandemic. It has resulted in thousands of deaths and placed enormous strain on communities, healthcare systems and healthcare workers as they battle shortages of ventilators, supplies, and difficulties in protecting patients and hospital staff alike. Challenges in managing the disease have led to new treatment and management strategies as healthcare teams struggle to adapt. We present the first case of COVID-19 managed in the austere deployed environment of Operation Inherent Resolve in which the patient was treated with dexamethasone, remdesivir, COVID-19 convalescent plasma, positive pressure ventilation, and proning. We discuss some of the inherent and unique challenges of caring for a patient in this resource constrained environment with a brief review of the literature on the treatment and management.


Subject(s)
Adenosine Monophosphate/analogs & derivatives , Alanine/analogs & derivatives , COVID-19 Drug Treatment , COVID-19/therapy , Dexamethasone/therapeutic use , Military Personnel , Respiratory Insufficiency/therapy , Adenosine Monophosphate/therapeutic use , Alanine/therapeutic use , Antiviral Agents/therapeutic use , Glucocorticoids/therapeutic use , Humans , Immunization, Passive , Male , Respiratory Insufficiency/diagnosis , Respiratory Insufficiency/virology , Young Adult , COVID-19 Serotherapy
5.
J Spec Oper Med ; 21(3): 11-20, 2021.
Article in English | MEDLINE | ID: mdl-34529799

ABSTRACT

Deployed medical providers at all roles of care must be prepared to recognize and manage acute coronary syndrome (ACS). Under optimal conditions, treatment is initiated with medical therapy and may be followed by prompt coronary angiography and revascularization. Emergent percutaneous coronary intervention (PCI) is not available in most deployed locations, however, and the time for such intervention is often dependent on long-range evacuation. This CPG provides guidance on best management for ACS patients in the deployed and resource-constrained environment.


Subject(s)
Acute Coronary Syndrome , Percutaneous Coronary Intervention , Acute Coronary Syndrome/diagnosis , Acute Coronary Syndrome/therapy , Coronary Angiography , Humans , Treatment Outcome
6.
J Spec Oper Med ; 20(4): 27-39, 2020.
Article in English | MEDLINE | ID: mdl-33320310

ABSTRACT

This Role 1 prolonged field care (PFC) guideline is intended for use in the austere environment when evacuation to higher level of care is not immediately possible. A provider must first be an expert in Tactical Combat Casualty Care (TCCC). The intent of this guideline is to provide a functional, evidence-based and experience-based solution to those individuals who must manage patients suspected of having or diagnosed with sepsis in an austere environment. Emphasis is placed on the basics of diagnosis and treatment using the tools most familiar to a Role 1 provider. Ideal hospital techniques are adapted to meet the limitations of austere environments while still maintaining the highest standards of care possible. Sepsis and septic shock are medical emergencies. Patients suspected of having either of these conditions should be immediately evacuated out of the austere environment to higher echelons of care. These patients are often complex, requiring 24-hour monitoring, critical care skills, and a great deal of resources to treat. Obtaining evacuation is the highest treatment priority for these patients. This Clinical Practice Guideline (CPG) uses the minimum, better, best paradigm familiar to PFC and gives medics of varying capabilities and resources options for treatment.


Subject(s)
Critical Care , Emergency Medical Services/methods , Military Medicine/methods , Practice Guidelines as Topic , Sepsis/therapy , Humans , Sepsis/diagnosis
7.
Mil Med ; 184(1-2): e280-e283, 2019 01 01.
Article in English | MEDLINE | ID: mdl-29947793

ABSTRACT

Myopericarditis following smallpox vaccination is a documented side effect with increasing incidence since reestablishing mandatory vaccination for deploying military personnel. After the ACAM2000 smallpox vaccine replaced the Dryvax smallpox vaccine, the rate of myopericarditis increased 50-fold.We describe six case reports of active duty soldiers who presented to the emergency department complaining of chest pain shortly after receiving routine pre-deployment vaccinations to include smallpox. All were hospitalized and became non-deployable after developing smallpox vaccination-associated myopericarditis.Some cases of smallpox vaccination-associated myopericarditis are diagnosed in soldiers in austere environments, which have led to the soldier being removed from the mission for months at a time. This can be avoided by having all soldiers who receive the smallpox vaccine screened for clinical evidence of myopericarditis at 30 days after receiving the vaccine. Contributing to the increasing rate of myopericarditis as well as the negative impact on soldier medical readiness, the continued use of the current ACAM2000 smallpox vaccine should be monitored.


Subject(s)
Myocarditis/etiology , Pericarditis/diagnosis , Smallpox Vaccine/adverse effects , Adolescent , Adult , Chest Pain/etiology , Electrocardiography/methods , Humans , Male , Military Personnel , Myocarditis/complications , Pericarditis/etiology , Smallpox/prevention & control , Smallpox Vaccine/therapeutic use
8.
Mil Med ; 183(11-12): e756-e757, 2018 11 01.
Article in English | MEDLINE | ID: mdl-29788215

ABSTRACT

A 20-year-old female presented to the emergency department complaining of fever, cough, and dyspnea after a recent camping trip. The patient remained ill appearing, persistently tachycardic and dyspneic despite nebulizer treatments, and fluids in the emergency department. She was admitted for observation and gradually improved over the next 4 d. Inpatient laboratory studies indicated acute Epstein-Barr virus infection and she was discharged with a presumptive diagnosis of infectious mononucleosis. However, further testing showed a simultaneous rickettsial infection producing murine typhus. The patient ultimately recovered uneventfully once proper treatment was initiated. This patient's presentation represents a unique description of simultaneous infectious mononucleosis and murine typhus which underscores the importance of maintaining a broad differential diagnosis in the approach to febrile illnesses.


Subject(s)
Infectious Mononucleosis/diagnosis , Typhus, Endemic Flea-Borne/diagnosis , Cough/etiology , Diagnosis, Differential , Female , Fever/etiology , Herpesvirus 4, Human/pathogenicity , Humans , Infectious Mononucleosis/complications , Typhus, Endemic Flea-Borne/complications , Young Adult
9.
Mil Med ; 183(11-12): e754-e755, 2018 11 01.
Article in English | MEDLINE | ID: mdl-29547908

ABSTRACT

In the United States, the rate of primary and secondary syphilis has increased by 18% in 2016, the highest rate since 1993. These patients can often present to the emergency department (ED) in various stages. Although syphilis is well described in the literature, there is a paucity of ED reports of atypical cases. A 22-yr-old male presented to the ED complaining of neck pain. The patient was found to have right-sided tender cervical lymphadenopathy causing neck pain. A thorough physical exam revealed diffuse lymphadenopathy. Without an obvious infectious etiology, the patient underwent a broad workup, which revealed a reactive rapid plasma reagin (RPR) assay with a titer of 1:64. The patient had no history of the classic painless penile ulcer. The ED presentation of secondary syphilis can be very insidious, and physicians should be aware of its various presentations.


Subject(s)
Syphilis/diagnosis , Anti-Bacterial Agents/therapeutic use , Emergency Service, Hospital/organization & administration , Humans , Lymphadenopathy/etiology , Male , Neck Pain/etiology , Penicillin G Benzathine/therapeutic use , Syphilis/complications , United States , Young Adult
10.
Mil Med ; 183(9-10): e378-e382, 2018 09 01.
Article in English | MEDLINE | ID: mdl-29420793

ABSTRACT

INTRODUCTION: Injuries sustained during Modern Army Combatives (MAC) tournaments can result in variable recovery time for involved competitors and unpredictable loss of readiness for military units. A paucity of MAC data is available to guide military medical providers and unit commanders on expected injuries or loss of readiness. Literature reviewing mixed martial arts competitions offers some insight but demonstrates variation in fight outcomes resulting in injuries ranging from 8.5% to 70% and it is difficult to effectively extrapolate such data to predict MAC tournament injuries. MATERIALS AND METHODS: This study retrospectively reviews pre- and post-competition medical records from two MAC tournaments held at Fort Hood in 2014 and 2015 to provide descriptive clinical information on injury patterns to practitioners and military commanders. RESULTS: Records from a total of 195 competitors with a mean age of 24.4 yr were analyzed with a total of 67 injuries, 29 of which resulted in duty limitations (14.8% of participants). Competitors participating in less-restrictive mixed martial arts style fighting (Advanced MAC) were 4.3 times more likely to sustain an injury than those limited to upper body grappling events (95% confidence interval 2.30-8.16). Military Acute Concussion Evaluations were reliably recorded both pre- and post-competition in 44% of total participants with no significant statistical difference between pre- and post-tournament evaluations. Duty profile limitations of injured competitors averaged 1 mo in duration. CONCLUSIONS: MAC tournaments result in injury rates comparable with other combative sports and military training courses.


Subject(s)
Martial Arts/injuries , Occupational Injuries/diagnosis , Adult , Female , Humans , Male , Martial Arts/statistics & numerical data , Military Personnel/statistics & numerical data , Retrospective Studies , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL